Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Julphar
Healthtrust
QuintilesIMS
Chubb
Fish and Richardson
Cipla

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,912,013

« Back to Dashboard

Summary for Patent: 5,912,013
Title: Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
Abstract:The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.
Inventor(s): Rudnic; Edward M. (North Potomac, MD), Belendiuk; George W. (Potomac, MD), McCarty; John (Biscayne Park, FL), Wassink; Sandra (Frederick, MD), Couch; Richard A. (Germantown, MD)
Assignee: Shire Laboratories, Inc. (Rockville, MD)
Application Number:08/426,394
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,912,013
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 5,912,013

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Moodys
Express Scripts
McKesson
Boehringer Ingelheim
Accenture
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.